Srinidhi Biotech Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 2.21 Cr
- Company Age 15 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.81 Cr
- Revenue Growth 10.96%
- Profit Growth 78.93%
- Ebitda 5.19%
- Net Worth 2.57%
- Total Assets 109.55%
About Srinidhi Biotech
Srinidhi Biotech Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 April 2009 and has a history of 15 years and nine months. Its registered office is in Gulbarga, Karnataka, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.21 Cr.
The company currently has active open charges totaling ₹10.81 Cr.
Lingaraj Appa and Deepali Appa serve as directors at the Company.
Company Details
-
Location
Gulbarga, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999KA2009PTC049684
-
Company No.
049684
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Apr 2009
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Srinidhi Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lingaraj Appa
|
Director | 27-Apr-2009 | Current |
|
Deepali Appa
|
Director | 27-Apr-2009 | Current |
Financial Performance of Srinidhi Biotech.
Srinidhi Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 10.96% increase. The company also saw a substantial improvement in profitability, with a 78.93% increase in profit. The company's net worth moved up by a moderate rise of 2.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Srinidhi Biotech?
In 2022, Srinidhi Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Nawan Ventures Private LimitedLingaraj Appa is a mutual person
Charges (Loans)
₹10.81 Cr
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 10.81 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Feb 2024 | Canara Bank | ₹3.76 Cr | Open |
| 07 Apr 2021 | Canara Bank | ₹4.50 Cr | Open |
| 31 Mar 2015 | Canara Bank | ₹2.55 Cr | Open |
How Many Employees Work at Srinidhi Biotech?
Unlock and access historical data on people associated with Srinidhi Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Srinidhi Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srinidhi Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.